BioSpace News Archive

Policy

Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission of NDA to U.S. FDA for Patisiran

This submission allows the FDA to review completed portions of the NDA on an ongoing basis. Alnylam expects to submit final clinical data by year end.

November 17, 2017
·
3 min read
Drug Development

Agios Presents Updated Phase I Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients With IDH1 Mutant Positive Glioma

The data were presented today in an oral presentation at the Society for Neuro-Oncology Annual Meeting in San Francisco.

November 17, 2017
·
9 min read
Business

Celyad Announces Third Quarter 2017 Business Update

The Company ended the quarter with €40 million in cash.

November 17, 2017
·
9 min read
Deals

scPharmaceuticals Nabs $89.6M in IPO

The company’s common stock will begin trading on the Nasdaq under the ticker symbol “SCPH” today.

November 17, 2017
·
2 min read
Business

Precipio to Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

Management will host a conference call on Tuesday, November 21, 2017 at 9:00am to review financial results and provide a corporate update.

November 17, 2017
·
2 min read
BioMidwest

Takeda and Cognition Kit Present Results From Digital Wearable Technology Study in Patients With Major Depressive Disorder (MDD)

Takeda and Cognition Kit today announced that the companies will present results from MDD-5003.

November 17, 2017
·
4 min read
Medicure Announces Repayment of Outstanding Debt

Medicure today announced that it has repaid in full its loans with the MDC and Crown Capital Fund IV, LP, an investment fund managed by Crown.

November 17, 2017
·
4 min read
Business

GI Dynamics to Provide Corporate Update and 2017 Third Quarter Results

The company will host a webcast at 4 PM EST 21 November 2017 | 8 AM AEDT 22 November 2017.

November 17, 2017
·
1 min read